Measuring Regenerative Medical Technology

Dr. Jan Nolta is the Director of the Stem Cell Program at UC Davis School of Medicine. Her current research is focused on developing therapies that will use mesenchymal stem cells (MSCs) to deliver factors for treating Huntington's disease and other disorders and injuries. Her group focuses on "bench to the bedside" research, and she has been involved in numerous clinical trials of gene and cell therapy. This talk will address how the field of regenerative medicine can advance into the future of medicine and healthcare hand in hand with devices and wearable technologies to measure outcomes.